This webinar occurred on May 16, 2023 and continuing education expires on May 16, 2024
- Register to watch the recording
- Webinar Slides (PDF)
- Webinar transcript (PDF)
- Watch the webinar on Youtube
About the Webinar
The Washington Department of Health (DOH) hosted a webinar on Tuesday, May 16, 2023. The presenters discussed Washington State Department of Health’s recommendation to administer HPV vaccination starting at age 9, the importance and benefits of HPV vaccination, and clinic strategies to support implementation of HPV vaccination at age 9. Continuing education is available for physicians, nurses, medical assistants, and pharmacists/pharmacy techs.
- Describe HPV-related cancers, and HPV vaccination rates in WA and in the US
- Identify at least 3 benefits of starting HPV vaccination at age 9
- Discuss clinic strategies to support workflows for HPV vaccination starting at age 9
Healthcare providers, pharmacists and pharmacy techs, local public health, and anyone interested in learning more about this topic.
Kathy Bay, DNP, RN
Clinical, Quality, and School Section Manager
Washington State Department of Health
Sherri Zorn, MD, FAAP
Washington HPV Free Taskforce
National HPV Vaccination Roundtable, Best Practices Taskgroup
Carrie Jenner, MD, FAAP
Medical Director of Pediatrics, Franciscan Medical Group
Amy Carter, MD
Chief Medical Officer, Allegro Pediatrics
- There is no charge for continuing education credit.
- Continuing education (CE) is available for physicians, nurses, medical assistants, pharmacists, and pharmacy technicians for attending the live webinar OR watching the recording.
- Even if you attend the live webinar or watch the recording as a group, everyone MUST register for the webinar and complete the evaluation as an individual prior to receiving CE.
- CE expires May 16, 2024.
- After attending the live webinar, an evaluation will be sent to you in an email.
- After watching the recording, please complete the evaluation. If you want CE credit, you must complete the evaluation.
- We will email certificates to everyone who requested CE.
Continuing Nursing Education
Continuing nursing education activity was approved by the Montana Nurses Association. MNA is accredited with distinction as a provider of nursing continuing professional development by the American Nurses Credentialing Center’s Commission on Accreditation. 1.0 contact hours will be awarded for successful completion of this activity.
Continuing Education for Medical Assistants
This program has been granted prior approval by the American Association of Medical Assistants (AAMA). Granting approval in no way constitutes endorsement by the AAMA of the program content or the program provider.
Continuing Education for Pharmacists and Pharmacy Technicians
This knowledge-based activity was approved by the Washington State Pharmacy Association for 1.0 contact hours.
Universal Activity Number (UAN):
The Washington State Pharmacy Association is accredited by the Accreditation Council for Pharmacy Education as a Provider of continuing pharmacy education.
Continuing Medical Education
Continuing Medical Education - Accreditation Statement
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of the Federation of State Medical Boards and the Washington Medical Commission. The Federation of State Medical Boards is accredited by the ACCME to provide continuing medical education for physicians.
Credit Designation Statement
The Federation of State Medical Boards designates this internet enduring activity for a maximum of 1.0 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
As an organization accredited by the ACCME, the Federation of State Medical Boards (FSMB) requires that the content of CME activities and related materials provide balance, independence, objectivity, and scientific rigor. All faculty, planners, and others in a position to control continuing medical education content participating in an accredited continuing education activity are required to disclose all financial relationships with ineligible companies. Ineligible companies are organizations whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients. Faculty (authors, presenters, speakers) are encouraged to provide a balanced view of therapeutic options by utilizing either generic names or other options available when utilizing trade names to ensure impartiality.
All faculty members are asked to disclose all financial relationships they have had in the past 24 months with ineligible companies regardless of the potential relevance of each relationship to the education and of the amount. The FSMB has implemented a mechanism to identify and resolve all conflicts of interest prior to the activity. The intent of this policy is to identify potential conflicts of interest so participants can form their own judgments with full disclosure of the facts. Participants will be asked to evaluate whether the speaker’s outside interests reflect a possible bias in the planning or presentation of the activity.
The speakers, course director, authors, and planners have no relevant financial relationships with ineligible companies to disclose.
Pam Kohlmeier, MD, JD, FACEP
Washington Medical Commission